1. Biomarkers of sequela in adult patients convalescing from COVID-19
- Author
-
Marsán-Suárez, Vianed, Casado-Hernández, Imilla, Hernández-Ramos, Elizabeth, Díaz-Domínguez, Gabriela, Triana-Marrero, Yenisey, Duarte-Pérez, Yaneisy, Miranda-Navarro, Jamilet, Bringas-Pérez, Ricardo, Simón-Pita, Ana María, Hernández-Rego, Yaquima de los Milagros, Miguel-Morales, Maydelín, Patria-Sánchez, Mysleidis, Zamora-González, Yaneth, Romero-Díaz, Yisenia, Aquino-Rojas, Suharmi, González-Díaz, Ihosvani, Merlín-Linares, Julio César, Leyva-Rodríguez, Aymara, Rodríguez-Pérez, Maylín, Benito-Caballero, Onasi, Navarro-Mariño, José Antonio, Elejalde-Larrinaga, Angel René, Elejalde-Tamayo, Claudia, Tam-Rey, Lázara Minerva, Ruiz-Villegas, Laura, de la Guardia-Peña, Odalis María, Jerez-Barcel, Yanet, Chang-Monteagudo, Arturo, Lam-Díaz, Rosa María, and Macías-Abraham, Consuelo Milagros
- Abstract
Different biomarkers for SARS-CoV-2 have been linked to detection, diagnosis, treatment, disease progression, and development of new drugs and vaccines. The objective of this research was to evaluate various hematological, biochemicals, immunological, radiological and spirometric parameters in 20 adult patients convalescing from COVID-19 and their possible relationship with the clinical course of the disease. The frequencies of categorical variables were compared using the chi-square and Fisher's exact test. The levels of statistical significance were denoted in each figure legend. Two-dimensional clustering analysis was performed using MeV software from TIGR. The tests with P value of ≤ 0.05 were considered statistically significant. Most of the patients studied presented alterations in dissimilar laboratory, radiological and spirometric parameters, which were related to the clinical evolution of the disease. The results obtained show that certain hematological, biochemical, immunological and radiological parameters can be considered as biomarkers of sequela in adult COVID-19 patients, which allows their stratification, according to the degree of involvement or sequela, into three groups: I (mild degree of involvement or sequela), without lung lesions on computerized axial tomography (CT scan) and high values of IgG, C3 and hemoglobin, II (moderate degree of involvement or sequel), without lung lesions on CT scan, characterized by high levels of CD3+/CD4+ T lymphocytes and the rest of the variables with low values and III (severe degree of involvement or sequela), with lung lesions on CT scan and high values of erythrocyte sedimentation rate, monocytes and neutrophils, associated with lymphopenia and decreased concentrations of IgG and C3.
- Published
- 2022
- Full Text
- View/download PDF